← Leaderboards
Ravindra L. Mehta
University Of California San Diego
$6,744,460
Attributed
$6,744,460
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $327.3K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,744,460 · 12
By mechanism
P30$3,066,743 · 2
K30$2,500,000 · 2
R01$1,153,205 · 1
M01$24,512 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Scott Mullaney$601,788
- Paul A Price$2,841,256
- Robert J Parmer$2,470,759
- Thomas R Moore$5,104,359
- Barry Lebowitz$1,639,424
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResourcesResearch PersonnelAcute Renal Failure With Renal Papillary NecrosisGrantBaseFundingResearch StudyDesignEpidemiologyOnline SystemsTranslational ResearchKidneyInternational CenterBiological MarkersBiologicalAdultClinical DataBiobankFunctional DisorderDatabasesFollow-UpCoupledBasic Science
Grant awards (38)
Core A - Resource for Clinical Studies of AKI$299,374
P30 · FY2022 · DK · contact PI
Core A - Resource for Clinical Studies of AKI$299,376
P30 · FY2021 · DK · contact PI
Core A - Resource for Clinical Studies of AKI$327,302
P30 · FY2020 · DK · contact PI
Core A - Resource for Clinical Studies of AKI$298,464
P30 · FY2019 · DK · contact PI
Core A - Resource for Clinical Studies of AKI$316,557
P30 · FY2018 · DK · contact PI
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)$303,597
P30 · FY2017 · DK · contact PI
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)$307,567
P30 · FY2016 · DK · contact PI
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)$307,567
P30 · FY2015 · DK · contact PI
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)$307,567
P30 · FY2014 · DK · contact PI
Resource for Clinical Studies of AKI (Clinical Research/Genomics/Biorepository)$299,372
P30 · FY2013 · DK · contact PI
CONTINUOUS URINARY FLOW MEASUREMENT IN ACUTE KIDNEY INJURY$4,832
M01 · FY2010 · RR · contact PI
THE CHANGING PATTERN OF RENAL BIOMARKERS IN CARDIAC CATHERIZATION$4,314
M01 · FY2010 · RR · contact PI
Clinical Research Enhancement from Supplemental Training$300,000
K30 · FY2009 · RR · contact PI
THE CHANGING PATTERN OF RENAL BIOMARKERS IN CARDIAC CATHERIZATION$4,530
M01 · FY2009 · RR · contact PI
MARKERS FOR PROGRESSION TO CHRONIC KIDNEY DISEASE - ROLE OF KALLIKREIN$3,397
M01 · FY2009 · RR · contact PI
Clinical Research Enhancement from Supplemental Training$300,000
K30 · FY2008 · RR · contact PI
MARKERS FOR PROGRESSION TO CHRONIC KIDNEY DISEASE - ROLE OF KALLIKREIN$3,205
M01 · FY2008 · RR · contact PI
Clinical Research Enhancement from Supplemental Training$300,000
K30 · FY2007 · RR · contact PI
Clinical Research Enhancement from Supplemental Training$300,000
K30 · FY2006 · RR · contact PI
Clinical Research Enhancement from Supplemental Training$300,000
K30 · FY2005 · RR
CONTINUOUS RENAL REPLACEMENT THERAPY DOSE IN ACUTE RENAL FAILURE$3,053
M01 · FY2005 · RR
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING$200,000
K30 · FY2004 · HL
Renal Replacement Therapy Dose in Acute Renal Failure$1,181
M01 · FY2004 · RR
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING$200,000
K30 · FY2003 · HL
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING$200,000
K30 · FY2002 · HL
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2002 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2002 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2002 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2002 · RR
PREDICTING AND IMPROVING OUTCOMES IN ACUTE RENAL FAILURE$587,981
R01 · FY2001 · DK
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING$200,000
K30 · FY2001 · HL
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2001 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2001 · RR
PREDICTING AND IMPROVING OUTCOMES IN ACUTE RENAL FAILURE$565,224
R01 · FY2000 · DK
CLINICAL RESEARCH ENHANCEMENT FROM SUPPLEMENTAL TRAINING$200,000
K30 · FY2000 · HL
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2000 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2000 · RR
NITRIC OXIDE IN RENAL DISEASE AND UREMIA$0
M01 · FY2000 · RR